tiprankstipranks
Lixte Biotechnology Holdings (LIXT)
NASDAQ:LIXT
US Market
LIXT
Lixte Biotechnology Holdings
RESEARCH TOOLSreports

Lixte Biotechnology Holdings (LIXT) Financial Statements

102 Followers

Lixte Biotechnology Holdings Financial Overview

Lixte Biotechnology Holdings's market cap is currently $35.43M. The company's EPS TTM is $-1.594; its P/E ratio is -18.70; Lixte Biotechnology Holdings is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -5.11M$ -3.57M$ -5.09M$ -6.31M$ -6.72M
EBITDA$ -6.00M$ -3.57M$ -5.07M$ -6.30M$ -6.72M
Net Income$ -6.01M$ -3.59M$ -5.09M$ -6.31M$ -6.73M
Balance Sheet
Cash & Short-Term Investments$ 5.11M$ 1.04M$ 4.20M$ 5.35M$ 4.82M
Total Assets$ 12.73M$ 1.15M$ 4.31M$ 5.56M$ 5.09M
Total Debt$ 664.49K$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -4.44M$ -1.04M$ -4.20M$ -5.35M$ -4.82M
Total Liabilities$ 1.77M$ 318.28K$ 313.86K$ 395.76K$ 302.93K
Stockholders' Equity$ 9.66M$ 827.22K$ 3.99M$ 5.17M$ 4.79M
Cash Flow
Free Cash Flow$ -3.07M$ -3.16M$ -4.29M$ -4.61M$ -4.14M
Operating Cash Flow$ -3.07M$ -3.16M$ -4.29M$ -4.61M$ -4.14M
Investing Cash Flow$ -3.17M$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 10.31M$ 0.00$ 3.14M$ 5.14M$ 3.90M
Currency in USD

Lixte Biotechnology Holdings Earnings and Revenue History

Income Statement >

Lixte Biotechnology Holdings Debt to Assets

Balance Sheet >

Lixte Biotechnology Holdings Cash Flow

Cash Flow >

Lixte Biotechnology Holdings Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >